Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IITerminatedD-0225-2023

Drug recall · February 1, 2023

NADH 10MG/ML recall

Why: Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Class II: could cause temporary or reversible health problems; serious harm is remote.

The recall

Product

NADH 10MG/ML (10ML VIAL) INJECTABLE, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.

Lots / codes

t20221108@46

Quantity
N/A
Company
Pharmacy Innovations, Erie, PA
Distribution
Nationwide in the USA
Initiated
December 22, 2022 · Voluntary: Firm initiated
Classified
January 26, 2023
Reported
February 1, 2023
Ended
July 31, 2024
How notified
Telephone

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Recalled with it (same recall event)

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.